Single-photon emission computed tomography (SPECT)
Showing 51 - 75 of >10,000
Amyloidosis Trial in Berkeley, Sacramento, San Jose (I124-AT01 only)
Active, not recruiting
- Amyloidosis
- I124-AT01 only
-
Berkeley, California
- +2 more
Sep 12, 2022
Venous Thrombosis Trial in Seoul ([18F]GP1 positron emission tomography/computed tomography)
Recruiting
- Venous Thrombosis
- [18F]GP1 positron emission tomography/computed tomography
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 15, 2022
Use of 99mTc Tilmanocept for Imaging Arterial Inflammation
Completed
- HIV
- Arterial Imaging
-
Boston, MassachusettsMassachusetts General Hospital
Apr 4, 2022
Lung Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Lung Trial in Chicago (procedure, other,
Not yet recruiting
- Lung Carcinoma
- +5 more
- Computed Tomography
- +6 more
-
Chicago, IllinoisNorthwestern University
Mar 24, 2023
Adult Medulloblastoma, Childhood Medulloblastoma, Neuroblastoma Trial in Iowa City (drug, procedure, radiation)
Completed
- Adult Medulloblastoma
- +4 more
- gallium Ga 68-edotreotide
- +4 more
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Aug 26, 2021
SPECT/CT Positive Lumbar Degenerative Disc Disease
Active, not recruiting
- Degenerative Disc Disease
- Back Pain, Low
- Lumbar fusion
-
Prague, Czechia
- +1 more
Dec 25, 2022
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in
Active, not recruiting
- Adult Primary Hepatocellular Carcinoma
- +6 more
- PET scan
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 21, 2022
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,
Not yet recruiting
- Limited Stage Lung Small Cell Carcinoma
- +3 more
- Cisplatin
- +8 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Nov 10, 2023
Sharing Methodologies for Quality Control in Diagnostic Imaging
Recruiting
- Subjects Undergoing Diagnostic Imaging Tests
- imaging tests
-
Naples, ItalyIRCCS Synlab SDN
Mar 3, 2023
Coronary Artery Disease Trial in Mainz (Photon Counting Detector Coronary Computed Tomography Angiography)
Not yet recruiting
- Coronary Artery Disease
- Photon Counting Detector Coronary Computed Tomography Angiography
-
Mainz, Rhineland-Palatinate, GermanyUniversity Medical Center Mainz
May 23, 2023
Squamous Cell Carcinoma of the Nasal Vestibule Trial in Amsterdam, Nijmegen (Sentinel node procedure)
Recruiting
- Squamous Cell Carcinoma of the Nasal Vestibule
- Sentinel node procedure
-
Amsterdam, Netherlands
- +1 more
Nov 24, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Radium-223
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 20, 2023
Functional Dyspepsia Trial in Rochester (Tradipitant, Placebo)
Not yet recruiting
- Functional Dyspepsia
- Tradipitant
- Placebo
-
Rochester, MinnesotaVanda Investigational Site
Dec 7, 2022
Coronary Disease Trial in Zhengzhou (remote ischemic preconditioning (RIPC))
Recruiting
- Coronary Disease
- remote ischemic preconditioning (RIPC)
-
Zhengzhou, Henan, ChinaFuwai central China cardiovascular Hospital
Mar 29, 2022
Melanoma Trial in Sittard (Diagnostic Test: Sentinel node mapping using MRI)
Not yet recruiting
- Melanoma
- Diagnostic Test: Sentinel node mapping using MRI
-
Sittard, Limburg, NetherlandsZuyderland Medical Center
Jul 11, 2022
Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of
Not yet recruiting
- Bone Metastases
- Urogenital Cancer
- Tc-99m MDP and gamma camera
- (no location specified)
Oct 26, 2022
Thyroid Disease Trial in Syracuse (SPECT)
Enrolling by invitation
- Thyroid Disease
- SPECT
-
Syracuse, New YorkSUNY Upstate Medical University
Aug 31, 2023
Fever of Unknown Origin Trial in Palo Alto (68Ga-Citrate PET/MRI, 67Ga-Citrate SPECT, Positron Emission Tomography)
Unknown status
- Fever of Unknown Origin
- 68Ga-Citrate PET/MRI
- +4 more
-
Palo Alto, CaliforniaStanford University
Oct 23, 2019
Viable Myocardium Detected by Hybrid PET/MR and SPECT for
Recruiting
- Chronic Total Occlusion of Coronary Artery
- CTO PCI
-
Nanjing, Jiangsu, ChinaFirst Affiliated Hospital of Nanjing Medical University
Oct 30, 2023
Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,
Recruiting
- Systemic Amyloidosis
- 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
- 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
-
Knoxville, TennesseeUniversity of Tennessee Graduate School of Medicine
Jul 10, 2023
Alzheimer Trial in New Haven (MNI-330 as a brain SPECT tracer of Beta-Amyloid)
Terminated
- Alzheimer Disease
- MNI-330 as a brain SPECT tracer of Beta-Amyloid
-
New Haven, ConnecticutInstitute for Neurodegenerative Disorders
Apr 1, 2019
Multiple System Atrophy Trial in Irvine, Columbus (AAV2-GDNF gene therapy, Sham (Placebo) Surgery)
Recruiting
- Multiple System Atrophy
- AAV2-GDNF gene therapy
- Sham (Placebo) Surgery
-
Irvine, California
- +1 more
Jan 18, 2023
Alzheimer's Disease Trial in New Haven (I123MNI388/I123MNI390)
Terminated
- Alzheimer's Disease
-
New Haven, ConnecticutInstitute for Neurodegenerative Disorders
Apr 1, 2019
Parkinson Disease Trial in New Haven (B-CIT and SPECT imaging)
Completed
- Parkinson Disease
- B-CIT and SPECT imaging
-
New Haven, ConnecticutInstitute for Neurodegenerative Disorders
Jul 1, 2022
CXCR4, PET/CT, Hematological Malignancy Trial in Wuhan (68Ga-pentixafor, PET/CT)
Not yet recruiting
- CXCR4
- +2 more
- 68Ga-pentixafor
- PET/CT
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Feb 15, 2022